–
Actuate Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−20.2
FY23:
−25.0
FY24:
−25.2
FY25:
−22.5
(positive)
Change from FY22 to FY25
millions USD
FY22:
−20.2
FY23:
−24.6
FY24:
−27.5
FY25:
−22.2
(positive)
Change from FY22 to FY25
millions USD
FY22:
−20.2
FY23:
−24.7
FY24:
−27.3
FY25:
−22.2
(positive)
Change from FY22 to FY25
millions USD
FY22:
−20.2
FY23:
−24.7
FY24:
−27.3
FY25:
−22.2
All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.